|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar
|
|
2
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinoma-an update. Cancer J Clin.
65:401–421. 2015. View Article : Google Scholar
|
|
3
|
Gillison ML, Chaturvedi AK, Anderson WF
and Fakhry C: Epidemiology of human papillomavirus-positive head
and neck squamous cell carcinoma. J Clin Oncol. 33:32–37. 2015.
View Article : Google Scholar
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar
|
|
5
|
Tamada M, Suematsu M and Saya H: Pyruvate
kinase M2: Multiple faces for conferring benefits on cancer cells.
Clin Cancer Res. 18:5554–5561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo W and Semenza GL: Emerging roles of
PKM2 in cell metabolism and cancer progression. Trends Endocrinol
Metab. 23:560–566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dayton TL, Jacks T and Vander Heiden MG:
PKM2, cancer metabolism, and the road ahead. EMBO Rep.
17:1721–1730. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Christofk HR, Vander Heiden MG, Harris MH,
Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL and
Cantley LC: The M2 splice isoform of pyruvate kinase is important
for cancer metabolism and tumour growth. Nature. 452:230–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Burns JS and Manda G: Metabolic pathways
of the Warburg effect in health and disease: Perspectives of
choice, chain or chance. Int J Mol Sci. 18:27552017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou ZF, Li M, Zhang L, Zhao H, Şahin Ö,
Chen J, Zhao JJ, Songyang Z and Yu D: Oncogenic kinase-induced PKM2
tyrosine 105 phosphorylation converts nononcogenic PKM2 to a tumor
promoter and induces cancer stem-like cells. Cancer Res.
78:2248–2261. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu FB, Ma FF, Wang YY, Hao L, Zeng H, Jia
C, Wang Y, Liu P, Ong IM, Li B, et al: PKM2 methylation by CARM1
activates aerobic glycolysis to promote tumorigenesis. Nat Cell
Biol. 19:1358–1370. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li M, Bai YT, Han K, Li XD and Meng J:
Knockdown of ectodysplasin-A receptor-associated adaptor protein
exerts a tumor-suppressive effect in tongue squamous cell carcinoma
cells. Exp Ther Med. 19:3337–3347. 2020.PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu H, Zhang W, Wu Z, Liu Y, Shi Y, Gong J,
Shen W and Liu C: miR-29c-3p regulates DNMT3B and LATS1 methylation
to inhibit tumor progression in hepatocellular carcinoma. Cell
Death Dis. 10:482019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Estilo CL, O-charoenrat P, Talbot S, Socci
ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y,
Boyle JO, et al: Oral tongue cancer gene expression profiling:
Identification of novel potential prognosticators by
oligonucleotide microarray analysis. BMC Cancer. 9:112009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar
|
|
18
|
Solomon B, Young RJ and Rischin D: Head
and neck squamous cell carcinoma: Genomics and emerging biomarkers
for immunomodulatory cancer treatments. Semin Cancer Biol.
52:228–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Omura K: Current status of oral cancer
treatment strategies: Surgical treatments for oral squamous cell
carcinoma. Int J Clin Oncol. 19:423–430. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ali J, Sabiha B, Jan HU, Haider SA, Khan
AA and Ali SS: Genetic etiology of oral cancer. Oral Oncol.
70:23–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hussein AA, Forouzanfar T, Bloemena E, de
Visscher J, Brakenhoff RH, Leemans CR and Helder MN: A review of
the most promising biomarkers for early diagnosis and prognosis
prediction of tongue squamous cell carcinoma. Br J Cancer.
119:724–736. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim YJ and Kim JH: Increasing incidence
and improving survival of oral tongue squamous cell carcinoma. Sci
Rep. 10:78772020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu J: The Warburg metabolism fuels tumor
metastasis. Cancer Metastasis Rev. 38:157–164. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Icard P, Shulman S, Farhat D, Steyaert JM,
Alifano M and Lincet H: How the Warburg effect supports
aggressiveness and drug resistance of cancer cells? Drug Resist
Updat. 38:1–11. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilde L, Roche M, Domingo-Vidal M, Tanson
K, Philp N, Curry J and Martinez-Outschoorn U: Metabolic coupling
and the reverse Warburg effect in cancer: Implications for novel
biomarker and anticancer agent development. Semin Oncol.
44:198–203. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liberti MV and Locasale JW: The Warburg
effect: How does it benefit cancer cells? Trends Biochem Sci.
41:211–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg Effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun L, Suo C, Li ST, Zhang H and Gao P:
Metabolic reprogramming for cancer cells and their
microenvironment: Beyond the Warburg Effect. Biochim Biophys Acta
Rev Cancer. 1870:51–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wiese EK and Hitosugi T: Tyrosine kinase
signaling in cancer metabolism: PKM2 paradox in the Warburg effect.
Front Cell Dev Bio. 6:792018. View Article : Google Scholar
|
|
30
|
van Niekerk G and Engelbrecht AM: Role of
PKM2 in directing the metabolic fate of glucose in cancer: A
potential therapeutic target. Cell Oncol (Dordr). 41:343–351. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Z, Deng X, Liu Y, Liu Y, Sun L and
Chen F: PKM2, function and expression and regulation. Cell Biosci.
9:522019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang W, Zheng Y and Xia Y:
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2
promotes the Warburg effect. Nat Cell Biol. 14:1295–1304. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li T, Han J, Jia L, Hu X, Chen L and Wang
Y: PKM2 coordinates glycolysis with mitochondrial fusion and
oxidative phosphorylation. Protein Cell. 10:583–594. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miao Y, Lu M, Yan Q, Li SD and Feng YJ:
Inhibition of proliferation, migration, and invasion by knockdown
of pyruvate Kinase-M2 (PKM2) in ovarian cancer SKOV3 and OVCAR3
Cells. Oncol Res. 24:463–475. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang J, Cao R, Wang X, Zhang Y, Wang P,
Gao H, Li C, Yang F, Zeng R, Wei P, et al: Mitochondrial PKM2
regulates oxidative stress-induced apoptosis by stabilizing Bcl2.
Cell Res. 27:329–351. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu Q, Tu J, Dou C, Zhang J, Yang L, Liu X,
Lei K, Liu Z, Wang Y, Li L, et al: HSP90 promotes cell glycolysis,
proliferation and inhibits apoptosis by regulating PKM2 abundance
via Thr-328 phosphorylation in hepatocellular carcinoma. Mol
Cancer. 16:1782017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang W, He Q, Sun J, Liu Z, Zhao L, Lu Z,
Zhou X and Wang A: Pyruvate kinase M2 deregulation enhances the
metastatic potential of tongue squamous cell carcinoma. Oncotarget.
8:68252–68262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jing C, Qu X, Li Z, Wu C, Zhao M, Wang Y,
Sun S, Zhang S, Chen J, Qiao Y, et al: EGFRwt/vIII-PKM2-β-catenin
cascade affects proliferation and chemo-sensitivity in head and
neck squamous cell carcinoma. Am J Cancer Res. 7:2491–2502.
2017.PubMed/NCBI
|
|
39
|
Kurihara-Shimomura M, Sasahira T,
Nakashima C, Kuniyasu H, Shimomura H and Kirita T: The Multifarious
functions of pyruvate kinase M2 in oral cancer cells. Int J Mol
Sci. 19:29072018. View Article : Google Scholar : PubMed/NCBI
|
